[1]
“Recent findings on molecular alterations in IDH1, TP53, and CASP9 in gliomagenesis”, Biomed. Res. Ther., vol. 9, no. 10, pp. 5375–5383, Oct. 2022, doi: 10.15419/bmrat.v9i10.775.